Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 3Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Uveal Melanoma 1Ovarian Neoplasms 1Melanoma 1

Interventions

utomilumab 1tislelizumab 1spartalizumab 1entinostat 1cemiplimab 1Thrombopoietin 1Polyethylene Glycols 1Nivolumab 1Immunologic Techniques 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Cyclophosphamide 1Carboplatin 1Bevacizumab 1ADI PEG20 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uveal Melanoma × ADI PEG20 × Gynecologic × Clear all
NCT01665183 2016-02-25

Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma

Polaris Group

Phase 1 Completed
8 enrolled
DermatologicGynecologic

Uveal Melanoma, Melanoma, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡